Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /B2B Technology

B2B Technology

29 VCs and 2 funds investing in B2B Technology

VCs investing in B2B Technology

Allen Moseley

Managing General Partner

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Allen Moseley is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Alan Taetle

General Partner

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Alan Taetle is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Spence McClelland

General Partner

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Spence McClelland is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Vasant Kamath

General Partner

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Vasant Kamath is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Ryan Collins

Principal

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Ryan Collins is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Bill Hudson

Administrative Partner, CFO

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Bill Hudson is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Thomas Collier

Senior Associate

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Thomas Collier is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Brandon Aponte

Associate

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Brandon Aponte is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Missy Evans

Executive Assistant and Office Manager

80%

Noro-Moseley Partners

Check: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.

Missy Evans is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.

Series ASeries BGrowth Stage

Ilkka Kaikuvuo

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Ilkka Kaikuvuo is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Carl Haglund

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Carl Haglund is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Julianna Borsos

Chair, Founding Partner

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Julianna Borsos is listed by Bocap as Chair, Founding Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Vilma Torstila

Investment Director, Partner

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Vilma Torstila is listed by Bocap as Investment Director, Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Angelo Moita

Investment Director, Partner

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Angelo Moita is listed by Bocap as Investment Director, Partner. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Alexander Hänninen

Analyst

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Alexander Hänninen is listed by Bocap as Analyst. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Toivo Virrantuomi

Analyst

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Toivo Virrantuomi is listed by Bocap as Analyst. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Niklas Sonkin

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Niklas Sonkin is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Kimmo Kärkkäinen

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Kimmo Kärkkäinen is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Eeva Sipilä

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Eeva Sipilä is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Riikka Jakovuori

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Riikka Jakovuori is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Jacco ter Schegget

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Jacco ter Schegget is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Steven Myint

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Steven Myint is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Marc Mercer

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Marc Mercer is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Milja Saksi

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Milja Saksi is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Lasse Männistö

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Lasse Männistö is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Niclas Ahlström

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Niclas Ahlström is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Riitta Salonen

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Riitta Salonen is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Jarmo Nieminen

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Jarmo Nieminen is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Esa Matikainen

Expert

80%

Bocap

Check: The firm does not publish a standard check-size range on its current official website.

Esa Matikainen is listed by Bocap as Expert. No narrower personal thesis is asserted beyond the firm's published strategy: Back ambitious, established Finnish technology and software-led growth companies with €10M-€300M in revenue and help them expand internationally.

Growth Equity

Funds focused on B2B Technology

Bocap

Helsinki, Finland

20 people0 investments

Noro-Moseley Partners

Atlanta, Georgia

9 people0 investments